-
How Tesamorelin Works — and What Animal Studies Tell Us
Read More: How Tesamorelin Works — and What Animal Studies Tell UsTesamorelin (a GHRH analog) activates pituitary GHRH receptors, boosting pulsatile GH and hepatic IGF-1 to drive lipolysis and anti-lipogenic effects. Foundational animal studies in rats and dogs—supported by FDA reviews—show…
-
BPC-157: Between Regeneration Hype and Human Evidence
Read More: BPC-157: Between Regeneration Hype and Human EvidenceBPC-157, a gastric-derived peptide hailed for regenerative effects in animals, is gaining global attention despite minimal human evidence. This research briefing separates verified science from speculation — reviewing animal data,…
-
Regulatory Tightening: FDA Bulk Substance Policy Redefines Peptide Compounding
Read More: Regulatory Tightening: FDA Bulk Substance Policy Redefines Peptide CompoundingWhy it matters The U.S. FDA is moving from a period of discretionary enforcement to active restriction of unlisted bulk drug substances used in compounding. This shift directly impacts how…
